Moneycontrol
HomeNewsBusinessReal EstateCoronavirus pandemic | Another 'Black Swan' for residential market post-demonetisation
Trending Topics

Coronavirus pandemic | Another 'Black Swan' for residential market post-demonetisation

The coronavirus outbreak may lead to cash flow management issues in ongoing projects where a fall in collections may lead to a drop off in construction

March 20, 2020 / 14:13 IST
Story continues below Advertisement

The coronavirus outbreak is perhaps the fourth 'Black Swan' event being witnessed by the Indian real estate sector in since 2016, according to a report by ICICI Securities.

The real estate sector is still coming to terms with disruptions like RERA, GST implementation and the NBFC funding crisis.

Story continues below Advertisement

New launches planned in April-May 2020 will be pushed back till at least September 2020 to coincide with the festive season, the report noted.

Since early this month, the coronavirus scare scare has led to buyer footfalls falling off dramatically in the largest markets of MMR and NCR and to a lesser extent across South India. The prospect of falling sales in ongoing projects and deferment of upcoming launches may lead to a drop in construction activity, the report said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show